Arthur E. Frankel
Impact in
- Biotechnology top 0.2%
- Transgenic Plants and Applications
- Immunology top 0.5%
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
Papers in
- Immunology 89
- Toxin Mechanisms and Immunotoxins 82
-
- Transgenic Plants and Applications 40
- Cancer Research and Treatments 20
- Microbial Inactivation Methods 11
- Co-authors
- Andrew Hertler (8 shared papers)Eugene P. Frenkel (4 shared papers)Andrew Y. Koh (4 shared papers)Andrew Thorburn (12 shared papers)Yang Xie (3 shared papers)Laura Coughlin (2 shared papers)Thomas Froehlich (2 shared papers)Jiwoong Kim (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Blood (8 papers)Leukemia Research (6 papers)Molecular Cancer Therapeutics (6 papers)Bioconjugate Chemistry (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Arthur E. Frankel
143 papers receiving 5.1k citations
Arthur E. Frankel's Hit Papers
Peers
Comparison fields: 5 of 117
- Biotechnology 1.3k
- Immunology 2.5k
- Oncology 1.4k
- Molecular Biology 2.6k
- Cancer Research 495
Countries citing papers authored by Arthur E. Frankel
This map shows the geographic impact of Arthur E. Frankel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur E. Frankel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur E. Frankel more than expected).
Fields of papers citing papers by Arthur E. Frankel
This network shows the impact of papers produced by Arthur E. Frankel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur E. Frankel. The network helps show where Arthur E. Frankel may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur E. Frankel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A STING-activating nanovaccine for cancer immunotherapy Hit paper breakdown → | 2017 | 752 |
| 2 | Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients Hit paper breakdown → | 2017 | 496 |
| 3 | First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors Hit paper breakdown → | 2021 | 192 |
| 4 | 2014 | 192 | |
| 5 | Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins. | 1985 | 94 |
| 6 | 1989 | 90 | |
| 7 | 1990 | 84 | |
| 8 | 2019 | 81 | |
| 9 | 2008 | 78 | |
| 10 | 1985 | 73 | |
| 11 | 2007 | 70 | |
| 12 | 1989 | 68 | |
| 13 | 1997 | 66 | |
| 14 | Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells. | 1996 | 61 |
| 15 | Adhesion-dependent multicellular drug resistance. | 1999 | 59 |
| 16 | A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia. | 1988 | 58 |
| 17 | 2005 | 57 | |
| 18 | 1996 | 57 | |
| 19 | 1989 | 54 | |
| 20 | Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. | 1987 | 54 |
About Arthur E. Frankel
Arthur E. Frankel is a scholar working on Immunology, Biotechnology, Molecular Biology, Oncology and Genetics, having authored 144 papers that have together received 5.2k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (82 papers), Transgenic Plants and Applications (40 papers), Virus-based gene therapy research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Cancer Research and Treatments (20 papers), CAR-T cell therapy research (18 papers), Bacillus and Francisella bacterial research (15 papers) and Microbial Inactivation Methods (11 papers). The work is most often cited by research in Biotechnology (1.3k citations), Immunology (2.5k citations), Oncology (1.4k citations), Molecular Biology (2.6k citations) and Cancer Research (495 citations). Arthur E. Frankel has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrew Hertler, Eugene P. Frenkel, Andrew Y. Koh, Andrew Thorburn, Yang Xie, Laura Coughlin, Thomas Froehlich, Jiwoong Kim, Ugo Testa and Zhijian J. Chen. Their work appears in journals such as Journal of Clinical Oncology, Blood, Leukemia Research, Molecular Cancer Therapeutics and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.